Digital methylation-specific PCR: New applications for liquid biopsy.

Area of Science:

• Epigenetics
• Molecular Biology
• Pulmonology

Background:

• Epigenetic analysis is crucial for understanding disease, but lacks molecular markers for COPD treatment.
• COPD is a risk factor for severe COVID-19, highlighting the need for better diagnostic tools.
• Methylation-specific PCR (MSP-PCR) is a key technique for DNA methylation analysis.

Purpose of the Study:

• To apply Methylation-Specific digital PCR (MSP-dPCR) for evaluating the ADAM33 gene's methylation profile.
• To assess the potential of MSP-dPCR for diagnostic and prognostic applications in COPD and COVID-19 patients.
• To explore the utility of MSP-dPCR in liquid biopsy for disease assessment.

Main Methods:

• Utilized Methylation-Specific digital PCR (MSP-dPCR) technique.
• Analyzed the methylation profile of the ADAM33 gene.
• Collected samples from saliva and lung tissue biopsies of COPD and COVID-19 patients.

Main Results:

• MSP-dPCR successfully generated a measurable prediction of gene methylation rate.
• The study demonstrated the feasibility of using MSP-dPCR for analyzing DNA methylation in patient samples.
• The technique showed potential for accurate methylation profiling.

Conclusions:

• MSP-dPCR is a promising technique for evaluating gene methylation profiles in COPD and COVID-19.
• This combined technology holds potential for diagnostic and prognostic applications.
• MSP-dPCR is a powerful tool for liquid biopsy, offering new avenues for disease management.